Seagen Inc.
SGENDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001060736
Seagen Inc. was delisted in 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.4B in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 614
- Q3 2023, +29 vs. previous quarter
- 13F value
- $36.4B
- Reported value at the end of Q3 2023
- Superinvestors holding
- 0
- At the end of Q3 2023
Superinvestors holding SGEN, Q3 2023
No superinvestor reported holding SGEN at the end of Q3 2023.
Latest insider trades
Open-market purchases and sales by Seagen Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 (view filing) | Nov 10 | 3 days | Epstein David RCEO | SSale | −10.6K | $213.01 | −$2.26M | −7.2%136.6K after | |
| Nov 13, 2023 (view filing) | Nov 9 | 4 days | Himes Vaughn BChief Technical Officer | SSale | −8.79K | $213.32 | −$1.87M | −17.1%42.6K after | 2 lots |
| Sep 22, 2023 (view filing) | Sep 21 | 1 day | Dansey Roger DPresident, R&D & CMO | SSale | −71 | $206.50 | −$14.7K | −0.1%116.7K after | |
| Sep 22, 2023 (view filing) | Sep 21 | 1 day | Himes Vaughn BChief Technical Officer | SSale | −80 | $206.50 | −$16.5K | −0.2%51.4K after | |
| Sep 22, 2023 (view filing) | Sep 21 | 1 day | Liu Jean IChief Legal Officer | SSale | −64 | $206.50 | −$13.2K | −0.1%84.4K after | |
| Sep 22, 2023 (view filing) | Sep 21 | 1 day | Romp Charles REVP, Commercial U.S. | SSale | −45 | $206.50 | −$9.29K | −0.1%69.1K after | |
| Sep 22, 2023 (view filing) | Sep 21 | 1 day | Simpson Todd EChief Financial Officer | SSale | −80 | $206.50 | −$16.5K | −0.1%128.7K after | |
| Sep 8, 2023 (view filing) | Sep 7 | 1 day | Himes Vaughn BChief Technical Officer | SSale | −8.79K | $205.76 | −$1.81M | −14.6%51.4K after | |
| Sep 1, 2023 (view filing) | Aug 31 | 1 day | Dansey Roger DPresident, R&D & CMO | SSale | −4.03K | $206.97 | −$833.9K | −3.5%111.8K after | |
| Sep 1, 2023 (view filing) | Aug 31 | 1 day | Himes Vaughn BChief Technical Officer | SSale | −1.79K | $206.97 | −$371.5K | −3.4%51.4K after |
Top 10 13F holders, Q3 2023
The largest institutional positions in Seagen Inc. at the end of Q3 2023; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 44,554,162 | $9.45B | 54.48% | 00.0% | Unchanged |
| Vanguard Group Inc | 13,321,042 | $2.83B | 0.07% | +5,3840.0% | Added |
| Pentwater Capital Management LP | 12,880,000 | $2.73B | 26.31% | +3,250,500+33.8% | Added |
| BlackRock Inc. | 12,051,745 | $2.56B | 0.07% | +9,926+0.1% | Added |
| Primecap Management Co | 6,261,798 | $1.33B | 1.12% | +222,990+3.7% | Added |
| State Street Corp | 3,359,408 | $712.7M | 0.04% | +25,204+0.8% | Added |
| Millennium Management LLC | 3,065,700 | $650.4M | 0.68% | +1,432,165+87.7% | Added |
| Norges Bank | 2,554,682 | $542.0M | 0.11% | −152,337−5.6% | Reduced |
| Davidson Kempner Capital Management LP | 2,459,732 | $521.9M | 8.04% | +777,503+46.2% | Added |
| Citadel Advisors LLC | 2,428,418 | $515.2M | 0.56% | +1,666,890+218.9% | Added |